We are live on ! Find out more
ABMD

Abiomed Inc

Delisted

ABMD was delisted on the 21st of December, 2022.

297 hedge funds and large institutions have $4.67B invested in Abiomed Inc in 2016 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 116 increasing their positions, 116 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $18.9M | Put options by funds: $8.08M

0% more funds holding in top 10

Funds holding in top 10: 99 (0)

0% more repeat investments, than reductions

Existing positions increased: 116 | Existing positions reduced: 116

7% less first-time investments, than exits

New positions opened: 42 | Existing positions closed: 45

3% less funds holding

Funds holding: 305297 (-8)

8% less capital invested

Capital invested by funds: $5.1B → $4.67B (-$430M)

Holders
297
Holders Change
-8
Holders Change %
-2.62%
% of All Funds
7.42%
Holding in Top 10
9
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.23%
New
42
Increased
116
Reduced
116
Closed
45
Calls
$18.9M
Puts
$8.08M
Net Calls
+$10.8M
Net Calls Change
+$2.94M
Name Holding Trade Value Shares
Change
Change in
Stake
Primecap Management
1
Primecap Management
California
$527M -$3.7M -31,960 -0.7%
Vanguard Group
2
Vanguard Group
Pennsylvania
$374M +$24.4M +210,347 +7%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$297M +$189M +1,627,766 +162%
PAI
4
Palo Alto Investors
California
$214M +$2.22M +19,200 +1%
1832 Asset Management
5
1832 Asset Management
Ontario, Canada
$194M +$59.6M +514,900 +46%
BFA
6
BlackRock Fund Advisors
California
$185M +$1.06M +9,112 +0.6%
EWM
7
Essex Woodlands Management
Texas
$163M
BIT
8
BlackRock Institutional Trust
California
$139M +$6.03M +52,061 +4%
William Blair Investment Management
9
William Blair Investment Management
Illinois
$116M +$31.6M +272,428 +36%
State Street
10
State Street
Massachusetts
$116M -$8.27M -71,401 -7%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$82.7M +$21.5M +185,894 +34%
JSP
12
Jackson Square Partners
California
$79.9M +$4.63M +39,951 +6%
BCM
13
Brown Capital Management
Maryland
$79.1M +$11.3M +97,847 +16%
Baillie Gifford & Co
14
Baillie Gifford & Co
United Kingdom
$66.3M +$1.5M +12,928 +2%
GIM
15
Granahan Investment Management
Massachusetts
$64.5M +$31.5M +271,600 +90%
Janus Henderson Group
16
Janus Henderson Group
United Kingdom
$60.6M +$5.6M +48,351 +10%
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$59.5M +$2.67M +23,025 +5%
Renaissance Technologies
18
Renaissance Technologies
New York
$59M -$15.8M -136,323 -21%
Goldman Sachs
19
Goldman Sachs
New York
$57.7M -$8.8M -75,968 -13%
SI
20
Scout Investments
Missouri
$57.5M +$5.69M +49,099 +11%
ORI
21
Oak Ridge Investments
Illinois
$57.2M -$12M -103,676 -17%
Millennium Management
22
Millennium Management
New York
$55.6M +$51M +440,090 +824%
Norges Bank
23
Norges Bank
Norway
$53.7M -$4.31M -37,217 -7%
Macquarie Group
24
Macquarie Group
Australia
$46.5M -$10.2M -87,718 -18%
CM
25
Castleark Management
Illinois
$45.9M +$5.21M +45,012 +12%

ABMD Hedge Fund Activity: Q4 2016 in Review

297 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2016, worth a combined $4.67B — down 8.4% from $5.1B a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of ABMD and 42 opened new positions — a net loss of 3 holders — while 116 trimmed existing stakes and 116 added.

The largest buyer was Wellington Management Group, adding an estimated $189M. The largest seller was Lord, Abbett & Co, cutting an estimated $77.2M.

  • 297 institutional investors held Abiomed Inc (ABMD) as of Q4 2016, down from 305 in Q3 2016.
  • Funds reported $4.67B of Abiomed Inc stock for Q4 2016, down 8.4% quarter-over-quarter.
  • 42 funds opened new Abiomed Inc positions in Q4 2016 and 45 closed out, a net change of -3 holders.
  • The largest Abiomed Inc buyer in Q4 2016 was Wellington Management Group, an estimated $189M added.
  • The largest Abiomed Inc seller in Q4 2016 was Lord, Abbett & Co, an estimated $77.2M sold.

Based on aggregated 13F filings for Q4 2016.